Multimodality therapy improves survival in intramedullary spinal cord metastasis of lung primary
Authors:
Open Access
- 1 September 2017
- journal article
- Published by Medknow in Hematology/Oncology and Stem Cell Therapy
- Vol. 10 (3) , 143-150
Abstract
Background: Most metastatic spinal cord lesions are located either in the intradural, extramedullary, or in the epidural compartments. Intramedullary spinal cord metastasis (ISCM) is a rare central nervous system spread of cancer. The aim of this report was to evaluate ISCM in the published literature. Methods: A literature review of PubMed from 1960 to 2016 was undertaken for the publications having demographic, clinical, histological, and outcome data. Results: A total of 59 relevant papers were identified, showing 128 cases of intramedullary metastasis from lung cancer. The incidence of lung cancer as the primary malignancy with intramedullary metastasis was 56%. The median time from diagnosis of primary to intramedullary metastasis was 6 months. Survival improved with multimodality therapy compared to monotherapy (4 months vs. 6.3 months) (hazard ratio = 0.501; 95% confidence interval, 0.293–0.857). Conclusion: Lung cancer is the predominant cause of intramedullary involvement of the spinal cord. Overall prognosis is poor, although a multimodality approach was associated with improved survival.Keywords
This publication has 51 references indexed in Scilit:
- Intramedullary metastasis in breast cancer – A comprehensive literature reviewJournal of the Neurological Sciences, 2013
- Intramedullary Spinal Cord Metastases: A 20-Year Institutional Experience with a Comprehensive Literature ReviewWorld Neurosurgery, 2013
- Retrospective study of 19 patients with intramedullary spinal cord metastasisClinical Neurology and Neurosurgery, 2009
- Intramedullary Spinal Cord Metastasis as Initial Presentation of Systemic Cancer - Report of a Rare CaseCentral European Neurosurgery, 2007
- Intramedullary Spinal Cord MetastasisJournal of Spinal Disorders & Techniques, 2006
- Leptomeningeal Carcinomatosis and Intramedullary Spinal Cord Metastases from Lung CancerClinical Nuclear Medicine, 2001
- Intramedullary spinal cord metastases (ISCM) and non-small cell lung carcinoma (NSCLC): clinical patterns, diagnosis and therapeutic considerationsLung Cancer, 2001
- Intramedullary spinal cord metastasis from carcinoma of the lung: detection by positron emission tomographyEuropean Journal of Cancer, 1997
- Intramedullary spinal cord metastasesSpinal Cord, 1964
- Intramedullary spinal cord metastasisNeurology, 1960